Prostate cancer risk prediction models in Eastern Asian populations: current status, racial difference, and future directions
- PMID: 31187780
- PMCID: PMC7155801
- DOI: 10.4103/aja.aja_55_19
Prostate cancer risk prediction models in Eastern Asian populations: current status, racial difference, and future directions
Abstract
Prostate cancer (PCa) risk calculators (RCs) with prostate-specific antigen (PSA) and other risk factors can greatly improve the accurate prediction of potential risk of PCa compared to PSA. The European Randomized Study of Screening for PCa Risk Calculator (ERSPC-RC) and the Prostate Cancer Prevention Trial Risk Calculator (PCPT-RC) are developed on the Western population. However, the Western RCs showed limited diagnostic efficacy in the Eastern Asian population, mainly due to racial differences between the two populations. We aimed to review the application of Western RCs and Eastern Asian RCs in Eastern Asian cohorts and to identify the characteristics and efficacy of these RCs.
Keywords: Asians; nomogram; prediction models; prostate cancer; risk prediction.
Conflict of interest statement
None
Similar articles
-
Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL.BMJ Open. 2019 Nov 12;9(11):e031032. doi: 10.1136/bmjopen-2019-031032. BMJ Open. 2019. PMID: 31722940 Free PMC article.
-
European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study.BJU Int. 2016 Nov;118(5):706-713. doi: 10.1111/bju.13437. Epub 2016 Feb 29. BJU Int. 2016. PMID: 26833820 Clinical Trial.
-
Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.Eur Urol. 2012 Mar;61(3):577-83. doi: 10.1016/j.eururo.2011.11.012. Epub 2011 Nov 15. Eur Urol. 2012. PMID: 22104592
-
Risk calculators for the detection of prostate cancer: a systematic review.Prostate Cancer Prostatic Dis. 2024 Sep;27(3):544-557. doi: 10.1038/s41391-024-00852-w. Epub 2024 Jun 3. Prostate Cancer Prostatic Dis. 2024. PMID: 38830997
-
Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection.Asian J Androl. 2015 Nov-Dec;17(6):864-9. doi: 10.4103/1008-682X.156859. Asian J Androl. 2015. PMID: 26112489 Free PMC article. Review.
Cited by
-
TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.Mol Med Rep. 2020 Dec;22(6):5209-5218. doi: 10.3892/mmr.2020.11623. Epub 2020 Oct 21. Mol Med Rep. 2020. PMID: 33174061 Free PMC article.
-
DEFB126 polymorphisms and association with idiopathic asthenozoospermia in China.Asian J Androl. 2022 Nov-Dec;24(6):607-614. doi: 10.4103/aja2021115. Asian J Androl. 2022. PMID: 35381696 Free PMC article.
-
Combating Methotrexate Resistance in Cancer Treatment: A Review on Navigating Pathways and Enhancing Its Efficacy With Fat-Soluble Vitamins.Scientifica (Cairo). 2025 Apr 16;2025:8259470. doi: 10.1155/sci5/8259470. eCollection 2025. Scientifica (Cairo). 2025. PMID: 40270992 Free PMC article. Review.
-
Nutritional Quality of Conventional, Organic, and Hydroponic Tomatoes Commercialized in Quito, Ecuador.Foods. 2024 Apr 27;13(9):1348. doi: 10.3390/foods13091348. Foods. 2024. PMID: 38731718 Free PMC article.
-
Construction and Validation of a Clinical Predictive Nomogram for Improving the Cancer Detection of Prostate Naive Biopsy Based on Chinese Multicenter Clinical Data.Front Oncol. 2022 Jan 21;11:811866. doi: 10.3389/fonc.2021.811866. eCollection 2021. Front Oncol. 2022. PMID: 35127526 Free PMC article.
References
-
- Global Burden of Disease Cancer C. Fitzmaurice C, Allen C, Barber RM, Barregard L, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–48. - PMC - PubMed
-
- Yoon DK, Park JY, Yoon S, Park MS, Moon du G, et al. Can the prostate risk calculator based on Western population be applied to Asian population? Prostate. 2012;72:721–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous